ABOUT US
Company
Leadership
Board
Advisors
History
Investors
Join us
SCIENCE
LDHA
PIPELINE
NEWS
CONTACT US
中文

NEWS

META Nominates MP-5342 as First Pre-clinical Candidate for Inflammatory Bowel Disease 2025/10/15

META Nominates MP-5342 as First Pre-clinical Candidate for Inflammatory Bowel Disease 2025/10/15

The first candidate molecule derived from the innovative immunometabolism platform has completed preclinical development and is approaching the IND-enabling study stage.
Progress 2025.10.15
All General Progress Spotlight Honor Care
META Pharmaceuticals Inc. Named 2026 Prix Galien USA Best Startup Nominee

META Pharmaceuticals Inc. Named 2026 Prix Galien USA Best Startup Nominee

Honor
2026.08.19
META Wins Third Place at 2026 (North America) 5th Biomedical Pitch Competition

META Wins Third Place at 2026 (North America) 5th Biomedical Pitch Competition

The 2026 (North America) 5th Biomedical Pitch Competition, co-hosted by the Boston Capital Investment Club (BCIC) and Hong Kong Science and Technology Parks Corporation (HKSTP), recently concluded in Boston, USA.
Honor
2026.06.02
META Wins BEYOND Awards 2026 Innovation Award

META Wins BEYOND Awards 2026 Innovation Award

The BEYOND Awards 2026 Innovation Award winners have been announced. META stood out from 800 global innovation projects to win the BEYOND Awards 2026 Innovation Award.
Honor
2026.05.26
META Named to 2025 Deloitte China Seed Award for Pharmaceutical & Health List

META Named to 2025 Deloitte China Seed Award for Pharmaceutical & Health List

Honor
2025.12.19
META Pharmaceuticals Named to HolonIQ Asia Health Tech 200

META Pharmaceuticals Named to HolonIQ Asia Health Tech 200

Honor
2022.10.25

Discovery Begins Asking How Life Works

Copyright © 2026 Meta Pharmaceuticals Inc.
粤ICP备2026058060号